Authors

Document Type

Article

Publication Date

3-13-2019

Comments

This article has been peer reviewed. It is the author’s final published version in Alzheimer's Research and Therapy, Volume 11, Issue 1, March 2019, Article number 23.

The published version is available at https://doi.org/10.1186/s13195-019-0476-1. Copyright © Peterson et al.

Abstract

The first Lewy Body Dementia Association (LBDA) Research Centers of Excellence (RCOE) Investigator's meeting was held on December 14, 2017, in New Orleans. The program was established to increase patient access to clinical experts on Lewy body dementia (LBD), which includes dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD), and to create a clinical trials-ready network. Four working groups (WG) were created to pursue the LBDA RCOE aims: (1) increase access to high-quality clinical care, (2) increase access to support for people living with LBD and their caregivers, (3) increase knowledge of LBD among medical and allied (or other) professionals, and (4) create infrastructure for a clinical trials-ready network as well as resources to advance the study of new therapeutics.

Creative Commons License

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

PubMed ID

30867052

Language

English

Included in

Neurology Commons

Share

COinS